Annals of Clinical Microbiology, The official Journal of the Korean Society of Clinical Microbiology

6

Weeks in Review

4

Weeks to Publication
Indexed in KCI, KoreaMed, Synapse, DOAJ
Open Access, Peer Reviewed
pISSN 2288-0585 eISSN 2288-6850

Search Results for: Yeon-Joon Park

A Case Report of Saccharomyces cerevisiae Fungemia in a Premature Infant Following Probiotic Treatment

Case report Jaewoong Lee1, Hyunjung Kim1, Hae Kyung Lee1, Yeon-Joon Park2 Department of Laboratory Medicine, 1Uijeongbu St. Mary’s Hospital, Uijeongbu, 2Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea Corresponding to Hae Kyung Lee, E-mail: hkl@catholic.ac.kr Ann Clin Microbiol 2020;23(3):155-158. https://doi.org/10.5145/ACM.2020.23.3.5Received on 14 July 2020, Revised on 6 August 2020, Accepted on 6 August 2020, Published on 20 September 2020.Copyright © Korean Society of Clinical Microbiology. Abstract Probiotics are used to restore and maintain the healthy intestinal microflora. Although Saccharomyces cerevisiae (SC) is considered as a non-pathogenic yeast, administration of SC as a probiotic is associated with a rare cause of fungemia in immunocompromised patients with central venous catheter insertion. We encountered a case of SC fungemia in a premature infant who presented with respiratory distress syndrome and had undergone central venous catheterization. Keywords Central venous catheter, Fungemia, Premature birth , Probiotics, Saccharomyces cerevisiae Probiotics are live

Read More »

Species Identification of Coagulase Negative Staphylococci by Polymerase Chain Reaction-Restriction Fragment Length Polymorphism of Heat Shock Protein 60 Gene

Original article PDF Eun-Jee Oh, M.D., Jung-Do Jang, M.D., Yeon-Joon Park, M.D., Sun Moo Kim, M.D., Byung Kee Kim, M.D. Department of Clinical Pathology, College of Medicine, the Catholic University of Korea, Seoul, Korea Corresponding to Yeon-Joon Park Ann Clin Microbiol 2000;3(1):36-42.Copyright © Korean Society of Clinical Microbiology. Abstract Background: An accurate and rapid method for species identification of coagulase negative staphylococci (CNS) has been increasingly necessary for the clinical significance and planning the management of patients with staphylococcal infections. Recently, it has been reported that there is a highly conserved area on their 60KDa heat shock protein (HSP60) gene sequences between the interspecies of CNS and it can be amplified by a set of universal degenerate primer. This led us our attention to focus on whether the PCR-based RFLP method using Mse I restriction enzyme could be a useful tool for the species identification of CNS. Methods: In the present study, we

Read More »

Streptococcus pneumoniae Isolates with Decreased Susceptibility to Optochin

Case report PDF Seungok Lee, Jung-Joon Park, Eun-Jee Oh, Yeon-Joon Park, and Byung Kee Kim Department of Clinical Pathology, Kangnam St. Marys Hospital, The Catholic University of Korea, Seoul, Korea Corresponding to Yeon-Joon Park, E-mail: yjpk@cmc.cuk.ac.kr Ann Clin Microbiol 2002;5(1):59-61.Copyright © Korean Society of Clinical Microbiology. Abstract Streptococcus pneumoniae is the most common cause of community-acquired pneumonia in adults and an important agent in other infections, including meningitis, otitis media, and conjunctivitis, etc. The optochin susceptibility test is the most widely used method to discriminate S. pneumoniae from other streptococci. However, 0.8-1.5% of S. pneumoniae contain optochin resistant population. Recently, we experienced three cases of variants of S. pneumoniae with decreased susceptibility to optochin. Equivocal optochin disk test should be confirmed by bile solubility, agglutination test, or DNA probe test. (Korean J Clin Microbiol 2002;5(1):59-61) Keywords Optochin, Decreased susceptibility, Streptococcus pneumoniae

Read More »

Aminoglycoside Resistance in Gram-negative Bacilli

Review article PDF Yeon-Joon Park Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea Corresponding to Yeon-Joon Park, E-mail: yjpk@catholic.ac.kr Ann Clin Microbiol 2009;12(2):57-61.Copyright © Korean Society of Clinical Microbiology. Abstract Aminoglycosides are one of the clinically relevant antibiotics. They kill bacteria by binding to bacterial 30S subunit of ribosome. Resistance to aminoglycosides occurs by three different mechanisms: 1. Production of an enzyme that modifies aminoglycosides, 2. Impaired entry of aminoglycoside into the cell by altering the OMP permeability, decreasing inner membrane transport, or active efflux, 3. The receptor protein on the 30S ribosomal subunit may be deleted or altered as a result of a mutation. By far, enzymatic modification has been the most important mechanism. In this review, the mechanisms of action and resistance, and the prevalence of resistance due to acquisition of enzymes are briefly described. (Korean J Clin Microbiol 2009;12:57-61) Keywords Aminoglycoside

Read More »

Syndromic testing for sexually transmitted infection: current and future demand

Review article In Young Yoo Department of Laboratory Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea Corresponding to In Young Yoo, E-mail: yiy00@naver.com Ann Clin Microbiol 2023;26(1):1-9. https://doi.org/10.5145/ACM.2023.26.1.1Received on 9 January 2023, Revised on 27 February 2023, Accepted on 27 February 2023, Published on 20 March 2023.Copyright © Korean Society of Clinical Microbiology.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Sexually transmitted infections (STIs) are a major global public health problem, with significant social burden worldwide. Accurate and appropriate diagnosis and treatment of STIs are important for preventing the transmission of STIs as well as major health consequences of untreated STIs, such as infertility and certain cancer. For diagnosis of STIs, the application of

Read More »

On-field evaluation of exdia COVID-19 antigen point-of-care testing in the emergency department during the COVID-19 pandemic

Original article In Young Yoo1, Gun Dong Lee1, Hyojin Chae1, Chun Song Youn2, Eun-Jee Oh1, Yeon-Joon Park1 Department of 1Laboratory Medicine, 2Emergency Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea Corresponding to Yeon-Joon Park, E-mail: yjpk@catholic.ac.kr Ann Clin Microbiol 2022;25(3):73-78. https://doi.org/10.5145/ACM.2022.25.3.2Received on 25 January 2022, Revised on 1 May 2022, Accepted on 17 May 2022, Published on 20 September 2022.Copyright © Korean Society of Clinical Microbiology.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: We evaluated the diagnostic performance of the Exdia COVID-19 antigen test (Exdia Ag; Precision Biosensor Inc., Korea) as a point-of-care (POC) test performed in the emergency department (ED) for the rapid detection of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in

Read More »

Inhibitory effects of copper, brass, and stainless steel surfaces on multidrug-resistant microorganisms

Original article Jung-Beom Kim1, Jae-Kwang Kim2, Jaewoong Lee3, Hiun Suk Chae4, Hae Kyung Lee2, Yeon-Joon Park5 1Department of Food Science and Technology, Sunchon National University, Suncheon, 2Department of Laboratory Medicine, Uijeongbu St. Mary’s Hospital, The Catholic University of Korea, Uijeongbu, 3Incheon St. Mary’s Hospital, Incheon, 4Department of Internal Medicine, Uijeongbu St. Mary’s Hospital, Uijeongbu, 5Department of Laboratory Medicine, Seoul St. Mary’s Hospital, Seoul, Korea Corresponding to Hae Kyung Lee, E-mail: hkl@catholic.ac.kr Ann Clin Microbiol 2022;25(2):31-39. https://doi.org/10.5145/ACM.2022.25.2.1Received on 25 January 2022, Revised on 1 May 2022, Accepted on 17 May 2022, Published on 20 June 2022.Copyright © Korean Society of Clinical Microbiology.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: The aim of this study was to analyze the inhibitory effects of

Read More »

Three Adult Cases of Elizabethkingia meningoseptica Infection in a Korean Hospital

Case report PDF Jayoung Kim1, Yeon-Joon Park1, Soyoung Shin1, Yonggoo Kim1, Sun Hee Park2 Departments of 1Laboratory Medicine, 2Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea Corresponding to Yeon-Joon Park, E-mail: yjpk@catholic.ac.kr Ann Clin Microbiol 2011;14(4):153-157. https://doi.org/10.5145/KJCM.2011.14.4.153Copyright © Korean Society of Clinical Microbiology. Abstract Elizabethkingia meningoseptica (Chryseobacterium meningoseptica) is a ubiquitous Gram-negative bacillus in the natural and hospital environments. This microorganism causes neonatal meningitis but rarely causes infections in adults, with most adult cases occurring in severely immunocompromised patients. Since E. meningoseptica is inherently resistant to the usual empiric therapy aimed at Gram-negative bacilli and MIC breakpoints for resistance and susceptibility of E. meningoseptica have not been established by the Clinical and Laboratory Standards Institute, it is very difficult to select effective antibiotics for the treatment of E. meningoseptica infection. We report here three cases of E. meningoseptica isolates (two from blood and one from CSF)

Read More »

Evaluation of the AdvanSure MDR-TB GenoBlot Assay for Detection of Rifampin and Isoniazid Resistant Mycobacterium tuberculosis Complex in Respiratory Specimens

Original article PDF Jayoung Kim1, Yeon-Joon Park1, Nam Yong Lee2, Chulhun L . Chang3, Miae Lee4, Jong Hee Shin5 Department of Laboratory Medicine, 1College of Medicine, The Catholic University of Korea, Seoul, 2Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 3Pusan National University Yangsan Hospital, Yangsan, 4Ewha Womans University Mokdong Hospital, Seoul, 5Chonnam National University Medical School, Gwangju, Korea Corresponding to Yeon-Joon Park, E-mail: yjpk@catholic.ac.kr Ann Clin Microbiol 2012;15(4):117-124. https://doi.org/10.5145/KJCM.2012.15.4.117Copyright © Korean Society of Clinical Microbiology. Abstract Background: We evaluated the performance of the AdvanSure MDR-TB GenoBlot Assay kit (AdvanSure MDR-TB, LG Life Science, Korea) to detect mutations related to rifampin (RFP)- and isoniazid (INH)-resistant Mycobacterium tuberculosis complex in respiratory specimens.  Methods: From February 2010 to June 2010, a total of 542 M. tuberculosis clinical isolates were collected from pulmonary tuberculosis patients in six university hospitals across Korea. We analyzed the conventional drug susceptibility testing (DST) and compared the

Read More »

Strategies for Interpretive Standards of β-Lactams Susceptibility Testing and Identification of Extended-Spectrum β-Lactamases and Carbapenemases in Enterobacteriaceae

Review article PDF Yeon-Joon Park1, Wonkeun Song2 Department of Laboratory Medicine, 1College of Medicine, The Catholic University of Korea, Seoul, 2Hallym University College of Medicine, Chuncheon, Korea Corresponding to Wonkeun Song, E-mail: swonkeun@hallym.or.kr Ann Clin Microbiol 2013;16(3):111-119. https://doi.org/10.5145/ACM.2013.16.3.111Copyright © Korean Society of Clinical Microbiology. Abstract The Clinical and Laboratory Standards Institute (CLSI) and the European Committee on Antimicrobial Susceptibility Testing (EUCAST) have recently revised the susceptibility interpretive criteria of oxyimino-β-lactams and carbapenems for Enterobacteriaceae. According to the new criteria, susceptibility testing results are sufficient to detect extended-spectrum β-lactamases (ESBLs) and carbapenemases; it is not necessary to perform ESBL or carbapenemase detection tests for therapeutic purposes. Thus, it has been recommended that these related tests be performed only for infection control. These changes in the susceptibility guidelines are supported by some clinical cases and the results of pharmacodynamic and animal studies. However, differences still exist between the breakpoints established by the

Read More »